Publication Topic

Vincent M, Fitch S, Bylsma L, Thompson C, Rogers S, Britt J, Wikoff D. Integration of toxicological and epidemiological information to evaluate biological plausibility and causality of associations between inhaled formaldehyde (FA) and lymphohematopoietic (LHP) cancers. Abstract 5157, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024. 

DeVito M, Bokkers B, van Duursen MBM, van Ede K, Feeley M, Antunes Fernandes Gaspar E, Haws L,… Wheeler M,… Wikoff D, et al. 2024. The 2022 World Health Organization reevaluation of human and mammalian toxic equivalency factors for polychlorinated dioxins, dibenzofurans and biphenyls. Regul Toxicol Pharmacol 146(Jan):105525; doi: 10.1016/j.yrtph.2023.105525. PMID: 37972849.

Wikoff D, Ring C, DeVito M, Walker N, Birnbaum L, Haws L. 2023. Development and application of a systematic and quantitative weighting framework to evaluate the quality and relevance of relative potency estimates for dioxin-like compounds (DLCs) for human health risk assessment. Regul Toxicol Pharmacol 145(Dec):105500; doi: 10.1016/j.yrtph.2023.105500. PMID: 37866700.

Yoshino T, Hooda N, Younan D, Shitara K, Heinemann V,…, Suh M, Reichert H, et al. A meta-analysis of efficacy and safety from head-to-head first-line (1L) trials of epidermal growth factor receptor inhibitors (EGFRIs) versus bevacizumab in combination with chemotherapy (CT) doublets in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC) by sidedness. Abstract 127P, European Society for Medical Oncology (ESMO) Asia Congress. Ann Oncol 34(Sup 4):S1519; doi: 10.1016/j.annonc.2023.10.262. Singapore, December 2023.

Perry CS, Blanchette AD, Vivanco SN, Verwiel AH, Proctor DM. 2023. Use of physiologically based pharmacokinetic modeling to support development of an acute (24-hour) health-based inhalation guideline for manganese. Regul Toxicol Pharmacol 145:105518; doi: 10.1016/j.yrtph.2023.105518. PMID: 3786341.

Blatt A, Suh M, Walter E, Jr., Wood CT, Espinosa C, Enriquez-Bruce ME,…, Movva N, Reichert H, Fryzek JP, et al. Seasonality of infant respiratory syncytial virus associated bronchiolitis around the US since the onset of COVID-19: Results from four US health systems 2016-17 through 2022-23. Poster 1535431, IDWeek 2023, Boston, MA, October 2023.

Wharton GT, Becker C, Bennett D, Burcu M, Bushnell G, …, Movva N, …, Suh M, et al. Overview of global real world data sources for pediatric pharmacoepidemiological research. Poster 217, International Society for Pharmacoepidemiology (ICPE) annual meeting, Halifax, Nova Scotia, August 2023.

Daniels D, Wang D, Suryadevara M, Wolf Z, Nelson CB, Suh M, Movva N, Reichert H, Fryzek JP, et al. 2023. Epidemiology of RSV bronchiolitis among young children in central New York before and after the onset of the COVID-19 pandemic. Pediatr Infect Dis J 42(12):1056-1062; doi: 10.1097/INF.0000000000004101. PMID: 37725814.

Pastula S, Suh M, Jiang X, Reichert H, Movva N, Fryzek J, Simões EAF. Respiratory syncytial virus (RSV) and bronchiolitis epidemiology among the United States infant Medicaid populations in seven states. Poster 191, International Society for Pharmacoepidemiology (ICPE) Annual Meeting, Halifax, Nova Scotia, August 2023.

Suh M, Reichert H, Movva N, Fisher K, Wood CT, Wolf Z, et al. Pilot surveillance of infant lower respiratory tract infections and respiratory syncytial virus in the United States during the COVID pandemic. Poster 95, International Society for Pharmacoepidemiology (ICPE) Annual Meeting, Halifax, Nova Scotia, August 2023.